Nature5 年
Inhibition of Physiological Growth Hormone secretion by Atropine
Atropine was administered orally in a dose ... drugs should be further investigated in the management of very tall children.
Medscape1 个月
Pediatric poisoning from trimedoxime (TMB4) and atropine automatic injectors.
OBJECTIVE: To describe the effects of combined trimedoxime (TMB4) and atropine poisoning from automatic injectors (AI) in children. STUDY DESIGN: Data was collected from two sources: calls to the ...
Long-range view of vision correction brightens the world for myopic children
The Singapore Eye Research Institute now has grants to develop artificial intelligence in treating eye diseases. Read more at ...
Eyenovia to end eye drug study after missing late-stage goal, shares fall
(Reuters) -Eyenovia will discontinue a late-stage study for its experimental drug-device combination to treat ...
Zacks.com on MSN13 天
Eyenovia Stock Tumbles on Termination of Phase III Myopia Study
Eyenovia, Inc. EYEN announced the decision to terminate a phase III study evaluating its investigational drug-device product, ...
Yahoo Finance16 天
Eyenovia Provides Update on Phase 3 CHAPERONE Study
CHAPERONE is Eyenovia’s Phase 3 study evaluating its proprietary drug-device combination of low-dose atropine in the Company’s Optejet dispensing platform as a potential treatment for pediatric ...
Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst ...
On Friday, Eyenovia, Inc. (NASDAQ:EYEN) stock is trading lower after an update from the Phase 3 CHAPERONE study evaluating ...